0.026516
0.000000
0.000000
0.000000
0.026516
0.000000
0.000000
0.000000
0.014747
0.00000
0.00000
0.00000
Uson, I.
Sheldrick, G.M.
De La Fortelle, E.
Bricogne, G.
Di Marco, S.
Priestle, J.P.
Gruetter, M.G.
Mittl, P.R.E.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
8
90.00
90.00
90.00
37.713
37.713
67.812
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
O4 S -2
96.063
SULFATE ION
non-polymer
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
Structure Fold.Des.
FODEFH
1263
0969-2126
7
55
63
10.1016/S0969-2126(99)80009-4
10368273
The 1.2 A crystal structure of hirustasin reveals the intrinsic flexibility of a family of highly disulphide-bridged inhibitors.
1999
UK
Structure
STRUE6
2005
0969-2126
5
253
A New Structural Class of Serine Protease Inhibitors Revealed by the Structure of the Hirustasin-Kallikrein Complex
1997
UK
Structure
STRUE6
2005
0969-2126
5
585
Erratum. A New Structural Class of Serine Protease Inhibitors Revealed by the Structure of the Hirustasin-Kallikrein Complex
1997
US
Protein Sci.
PRCIEI
0795
0961-8368
6
109
Recombinant Hirustasin: Production in Yeast, Crystallization, and Interaction with Serine Proteases
1997
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100
1
BENT CRYSTAL
IMAGE PLATE
1996-11
MARRESEARCH
GE(111)
M
x-ray
1
1.050
1.0
BW7B
EMBL/DESY, Hamburg
1.050
SYNCHROTRON
EMBL/DESY, HAMBURG BEAMLINE BW7B
5886.788
HIRUSTASIN
1
man
polymer
96.063
SULFATE ION
2
syn
non-polymer
18.015
water
52
nat
water
no
no
TQGNTCGGETCSAAQVCLKGKCVCNEVHCRIRCKYGLKKDENGCEYPCSCAKASQ
TQGNTCGGETCSAAQVCLKGKCVCNEVHCRIRCKYGLKKDENGCEYPCSCAKASQ
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
medicinal leech
Hirudo
baker's yeast
Saccharomyces
sample
6421
Hirudo medicinalis
4932
Saccharomyces cerevisiae
1
2.0
40
TWO DIFFERENT INDEPENDENT METHODS WERE USED FOR STRUCTURE SOLUTION
5.45
pH 5.45
repository
Initial release
Version format compliance
Version format compliance
1
0
1999-04-27
1
1
2008-03-24
1
2
2011-07-13
Y
1998-10-14
REL
REL
SO4
SULFATE ION
HOH
water
SO4
100
2
SO4
SO4
100
A
SO4
101
2
SO4
SO4
101
A
HOH
1
3
HOH
HOH
102
A
HOH
2
3
HOH
HOH
103
A
HOH
3
3
HOH
HOH
104
A
HOH
4
3
HOH
HOH
105
A
HOH
5
3
HOH
HOH
106
A
HOH
6
3
HOH
HOH
107
A
HOH
7
3
HOH
HOH
108
A
HOH
8
3
HOH
HOH
109
A
HOH
9
3
HOH
HOH
110
A
HOH
10
3
HOH
HOH
111
A
HOH
11
3
HOH
HOH
112
A
HOH
12
3
HOH
HOH
113
A
HOH
13
3
HOH
HOH
114
A
HOH
14
3
HOH
HOH
115
A
HOH
15
3
HOH
HOH
116
A
HOH
16
3
HOH
HOH
117
A
HOH
17
3
HOH
HOH
118
A
HOH
18
3
HOH
HOH
119
A
HOH
19
3
HOH
HOH
120
A
HOH
20
3
HOH
HOH
121
A
HOH
21
3
HOH
HOH
122
A
HOH
22
3
HOH
HOH
123
A
HOH
23
3
HOH
HOH
124
A
HOH
24
3
HOH
HOH
125
A
HOH
25
3
HOH
HOH
126
A
HOH
26
3
HOH
HOH
127
A
HOH
27
3
HOH
HOH
128
A
HOH
28
3
HOH
HOH
129
A
HOH
29
3
HOH
HOH
130
A
HOH
30
3
HOH
HOH
131
A
HOH
31
3
HOH
HOH
132
A
HOH
32
3
HOH
HOH
133
A
HOH
33
3
HOH
HOH
134
A
HOH
34
3
HOH
HOH
135
A
HOH
35
3
HOH
HOH
136
A
HOH
36
3
HOH
HOH
137
A
HOH
37
3
HOH
HOH
138
A
HOH
38
3
HOH
HOH
139
A
HOH
39
3
HOH
HOH
140
A
HOH
40
3
HOH
HOH
141
A
HOH
41
3
HOH
HOH
142
A
HOH
42
3
HOH
HOH
143
A
HOH
43
3
HOH
HOH
144
A
HOH
44
3
HOH
HOH
145
A
HOH
45
3
HOH
HOH
146
A
HOH
46
3
HOH
HOH
147
A
HOH
47
3
HOH
HOH
148
A
HOH
48
3
HOH
HOH
149
A
HOH
49
3
HOH
HOH
150
A
HOH
50
3
HOH
HOH
151
A
HOH
51
3
HOH
HOH
152
A
HOH
52
3
HOH
HOH
153
A
n
1
1
A
n
2
2
A
GLY
3
n
3
GLY
3
A
ASN
4
n
4
ASN
4
A
THR
5
n
5
THR
5
A
CYS
6
n
6
CYS
6
A
GLY
7
n
7
GLY
7
A
GLY
8
n
8
GLY
8
A
GLU
9
n
9
GLU
9
A
THR
10
n
10
THR
10
A
CYS
11
n
11
CYS
11
A
SER
12
n
12
SER
12
A
ALA
13
n
13
ALA
13
A
ALA
14
n
14
ALA
14
A
GLN
15
n
15
GLN
15
A
VAL
16
n
16
VAL
16
A
CYS
17
n
17
CYS
17
A
LEU
18
n
18
LEU
18
A
LYS
19
n
19
LYS
19
A
GLY
20
n
20
GLY
20
A
LYS
21
n
21
LYS
21
A
CYS
22
n
22
CYS
22
A
VAL
23
n
23
VAL
23
A
CYS
24
n
24
CYS
24
A
ASN
25
n
25
ASN
25
A
GLU
26
n
26
GLU
26
A
VAL
27
n
27
VAL
27
A
HIS
28
n
28
HIS
28
A
CYS
29
n
29
CYS
29
A
ARG
30
n
30
ARG
30
A
ILE
31
n
31
ILE
31
A
ARG
32
n
32
ARG
32
A
CYS
33
n
33
CYS
33
A
LYS
34
n
34
LYS
34
A
TYR
35
n
35
TYR
35
A
GLY
36
n
36
GLY
36
A
LEU
37
n
37
LEU
37
A
LYS
38
n
38
LYS
38
A
LYS
39
n
39
LYS
39
A
ASP
40
n
40
ASP
40
A
GLU
41
n
41
GLU
41
A
ASN
42
n
42
ASN
42
A
GLY
43
n
43
GLY
43
A
CYS
44
n
44
CYS
44
A
GLU
45
n
45
GLU
45
A
TYR
46
n
46
TYR
46
A
PRO
47
n
47
PRO
47
A
CYS
48
n
48
CYS
48
A
SER
49
n
49
SER
49
A
CYS
50
n
50
CYS
50
A
ALA
51
n
51
ALA
51
A
LYS
52
n
52
LYS
52
A
ALA
53
n
53
ALA
53
A
n
54
54
A
n
55
55
A
0.1286
0.1803
0.127
0.1794
0.1772
0.2254
522
792
5.1
5.0
10289
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
VAL
16
A
O
VAL
16
A
N
VAL
23
A
N
VAL
23
1
A
HOH
130
D
HOH
1
A
CD
LYS
21
A
CD
LYS
21
1
Y
1
A
CE
LYS
21
A
CE
LYS
21
1
Y
1
A
NZ
LYS
21
A
NZ
LYS
21
1
Y
1
A
THR
1
A
THR
1
1
Y
1
A
GLN
2
A
GLN
2
1
Y
1
A
SER
54
A
SER
54
1
Y
1
A
GLN
55
A
GLN
55
1
Y
1
17.98
2.70
114.20
132.18
A
A
A
CB
CG
CD
GLU
GLU
GLU
9
9
9
B
B
N
1
13.23
2.20
113.40
126.63
A
A
A
CA
CB
CG
GLU
GLU
GLU
26
26
26
A
N
1
12.05
1.40
123.60
135.65
A
A
A
CD
NE
CZ
ARG
ARG
ARG
32
32
32
N
1
-11.71
1.20
123.30
111.59
A
A
A
OE1
CD
OE2
GLU
GLU
GLU
45
45
45
A
A
A
N
1
A
GLU
45
-106.16
62.60
ANISOTROPIC REFINEMENT REDUCED FREE R (NO CUTOFF) BY 2%
0.2254
0.1803
0.1794
1.20
25.2
4045
792
15894
4895
5.0
99.2
RANDOM
1
FREE R
0.0
AB INITIO
ENGH AND HUBER
MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-2
5
342.00
417.02
1.20
25.2
52
449
10
0
387
0.014
0.036
0.000
0.029
0.140
0.120
0.042
0.004
0.097
0.096
1.2
25.2
1BX7
15928
0.0
0.043
1
15.0
2.4
99.4
0.376
1.20
1.25
1.61
1.8
98.1
data collection
MARXDS
data reduction
MARSCALE
model building
SHELXL-97
refinement
SHELXL-97
data reduction
MARXDS
data scaling
MARSCALE
phasing
SHELXL-97
HIRUSTASIN
HIRUSTASIN FROM HIRUDO MEDICINALIS AT 1.2 ANGSTROMS
1
N
N
2
N
N
2
N
N
3
N
N
disulf
2.041
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
17
A
SG
CYS
17
1_555
disulf
2.026
A
CYS
11
A
SG
CYS
11
1_555
A
CYS
22
A
SG
CYS
22
1_555
disulf
2.048
A
CYS
24
A
SG
CYS
24
1_555
A
CYS
44
A
SG
CYS
44
1_555
disulf
2.027
A
CYS
29
A
SG
CYS
29
1_555
A
CYS
48
A
SG
CYS
48
1_555
disulf
2.044
A
CYS
33
A
SG
CYS
33
1_555
A
CYS
50
A
SG
CYS
50
1_555
ANTI-COAGULANT
ANTI-COAGULANT, PEPTIDIC INHIBITORS, CONFORMATIONAL FLEXIBILITY, SERINE PROTEASE INHIBITOR
A
TYR
46
A
TYR
46
1
A
PRO
47
A
PRO
47
-9.16
ANTA_HIRME
UNP
1
1
P80302
TQGNTCGGETCSAAQVCLKGKCVCNEVHCRIRCKYGLKKDENGCEYPCSCAKASQ
1
55
1BX7
1
55
P80302
A
1
1
55
2
anti-parallel
A
GLN
15
A
GLN
15
A
LEU
18
A
LEU
18
A
LYS
21
A
LYS
21
A
CYS
24
A
CYS
24
BINDING SITE FOR RESIDUE SO4 A 100
Software
6
BINDING SITE FOR RESIDUE SO4 A 101
Software
5
A
ARG
30
A
ARG
30
6
6_454
A
LYS
38
A
LYS
38
6
1_555
A
ALA
51
A
ALA
51
6
1_555
A
LYS
52
A
LYS
52
6
1_555
A
ALA
53
A
ALA
53
6
1_555
A
HOH
112
D
HOH
6
1_555
A
HIS
28
A
HIS
28
5
3_634
A
ARG
30
A
ARG
30
5
6_454
A
LYS
38
A
LYS
38
5
1_555
A
LYS
52
A
LYS
52
5
1_555
A
HOH
139
D
HOH
5
3_634
96
P 43 21 2